Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Stroke
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Stroke
    Antithrombotic Medication Use Not Improving Among Ischaemic Stroke Survivors - (DGNews)
    High Salt Intake Linked to Strokes, Cardiovascular Disease - (DGNews)
    TopAbstracts in Stroke 11/26/2009 - (DGNews)
    Obesity Leading Risk Factor of Left Atrial Enlargement During Aging - (DGNews)
    Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies - (BMJ)

    News archive

     Recent webcasts/CME - Stroke
    • The Evolving Role of Antiplatelet Therapy for Atrial Fibrillation: Highlights From the ACC Scientific Sessions 2009
    • Current Standard of Care for Stroke Prevention in Patients With Atrial Fibrillation (AF)
    • Aneurysm Rupture and Subarachnoid Hemorrhage Cerebral Revascularization: The Role of EC-IC Bypass in the 21st Century
      Stenting for Intracranial Atherosclerosis
      Diffusion-Weighted Imaging: Not All That Glitters Is Gold

      Webcasts/CME archive

       Recent cases - Stroke
        Adult Cor Triatriatum Presenting as Cardioembolic Stroke
        Pure Sensory Stroke Form Compression of Putaminal Hemorrhage: A Case Report
        An Echocardiographic-Confirmed Case of Atrial Myxoma Causing Cerebral Embolic Ischemic Stroke: A Case Report
        Diffusion-Negative MRI in Acute Ischemic Stroke: A Case Report
        F-18-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography for the Diagnosis of Takayasu's Arteritis in Stroke: A Case Report

        Cases archive
          




        my personal edition > stroke > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Intrathecal Baclofen Therapy Helps Hemiplegic Stroke Patients With Mobility: Presented at NASM

        By Lynn Haley
        Special to DG News

        SAN DIEGO, CA -- August 17, 2001 -- Stroke survivors with spastic hemiplegia show improvement in comfortable walking speed (CWS) following intrathecal baclofen therapy (ITB), according to a study by researchers at The Institute for Rehabilitation and Research at Baylor College of Medicine in Houston, Texas.

        Their findings were presented at the 2001 North American Stroke Meeting held here August 15th-18th.

        Researchers say that ITB therapy in stroke survivors can result in significant improvement in muscle tone while preserving muscle strength in the uninvolved lower limbs. For some patients, this tone reduction can result in improved ambulation.

        Investigators studied four men (ages 42, 47, 48 and 69), and four females (ages 42, 50, 55 and 68). All were stroke survivors who had been treated with other pharmacologic and physical therapies which had failed to provide adequate control of their spasticity.

        The patients underwent ITB pump implantation 14 to 55 months following their stroke.

        The average time from stroke-onset to pump implantation was approximately 27.8 months. Prior to receiving ITB, all patients had been ambulatory. Patients were then asked to walk a distance of 50 feet in three trials, with CWS being the mean. All were asked to walk at a speed them deemed comfortable.

        Results showed that at a mean 9.4 months following pump implantation, the average modified Ashworth Scale (MAS) lower limb muscle scores dropped from 2.22 to 0.54. Normal muscle strength (5/5) was preserved in the uninvolved lower limbs. Functional Independence Measure (FIM) mobility, which measures mobility in areas such as locomotion, sit-to-stand, stand-to-sit, stairs, and community ambulation, improved from an average of 17.8 to 22.5. As well, average timed ambulation for these patients over a distance of 50 feet showed improvement, dropping from 132 to 63.6 seconds.

        Researchers concluded that ITB therapy improves CWS as well as certain FIM-mobility in stroke survivors with spastic hemiplegia.

        The research was funded by Medtronic, Inc.



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send